Bone Health Technologies and San Francisco VA Health Care System with University of California, San Francisco to Begin Osteoporosis Prevention Study for Postmenopausal Women with Osteopenia 

San Francisco, CA (June 8, 2022), – Bone Health Technologies (BHT), the leading innovator in technologies for treating and preventing bone diseases such as osteoporosis, announces today that they will be conducting a 1-year long study of a novel, non-drug intervention to treat osteopenia in postmenopausal women, in partnership with the San Francisco Veterans Affairs…
Read more

Bone Health Technologies Awarded $2.7M NIH Commercialization Readiness Pilot Grant

San Francisco, CA (October 6, 2021)–Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health and preventing bone health diseases, announces today that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company $2.7M in a Commercialization Readiness Pilot (CRP) grant as part of the…
Read more


Bone Health Technologies, a leading innovator of technologies for improving bone health, announces today the close of its $2.5 million funding round and the appointment of three board members: Karen Drexler, MBA, Nancy Lynch, MD, MBA and Sam Goldberger, MD, MBA.

Bone Health Technologies Raises $2.5M In New Funding Round, Adds 3 Members To Board Bone Health Technologies, a MedTech company focused on treating osteoporosis, announced the completion of a new funding round and the appointment of new board members. Funding Secured: San Francisco, California-based Bone Health said it has closed a $2.5 million funding round. The company noted the funding was oversubscribed. Good Growth Capital led the funding round with…
Read more

Laura Yecies | OsteoBoost: A Vibration Belt to Prevent Osteoporosis

Interview with CEO Laura Yecies on Happy Bones, Happy Life podcast!

Health Tech Spotlight: Laura Yecies – CEO at Bone Health Technologies

CEO Laura Yecies is interviewed about how their easy-to-use medical device can prevent osteoporosis, winning the One Harvard New Venture Competition, and playing the violin!


“In terms of research funding, we have nothing to complain about — we have benefited from very generous grants — and what I find in my fundraising (is) if it’s a male audience where they don’t have a lot of domain expertise, they don’t get it,” Yecies said. “But it resonates with women, and I am getting more interest from women investors, angel investors and VC firms led by women.”

ViewPoints Interview: BoneHealth Technologies’ Laura Yecies Shares Insights on OsteoBoost Vibration Belt

In a recent interview with PharmaShots, Laura Yecies, CEO of BoneHealth Technologies shared her views on OsteoBoost Vibration Belt that has been granted “Breakthrough Device” designation by the US FDA.

FDA breakthrough device designation strengthens Osteoboost outlook

Bone Health Technologies Inc. may be on the verge of upstaging a common drug therapy, but don’t tell them to break a leg. The San Francisco-based company’s Osteoboost Vibration Belt received a U.S. FDA breakthrough designation for technology that delivers gentle stimulation to reduce bone loss and prevent osteoporosis with the goal of reducing the number of potentially devastating broken bones in the elderly.

Osteoporosis Prevention Product Wins FDA Breakthrough Device Designation

Bone Health Technologies, creator of the OsteoBoost Vibration Belt that promises to reduce the risk of osteoporosis, has been granted “Breakthrough Device” designation by the US Food & Drug Administration.